Table of Contents
- Overview
- Catalyst
- Summary
- Methodology
- Executive Summary
- Introduction
- From Idea to Market: Product Lifecycle Management in the Pharmaceutical
Industry (Market Focus)
- Optimizing PLM Technology for the Pharmaceutical Industry (Technology
Focus)
- Managing Process Complexity with PLM (Strategy Focus)
- Pharmaceutical Product Lifecycle Management Forecast in North America
2006-2012 (Databook)
- Pharmaceutical Product Lifecycle Management Forecast in Western Europe
2006-2012
- Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012
- Table of Contents
- Table of figures
- Table of tables
- From Idea to Market: Product Lifecycle Management in the Pharmaceutical
Industry (market focus)
- Summary
- Product lifecycle management will transform the drug development
lifecycle process
- The nature of a drug' s lifecycle necessitates a PLM strategy
- PLM addresses key business challenges facing the pharmaceutical industry
- A greater focus on decreasing time to market is driving adoption of PLM
- Harmonizing product portfolios from M&A activities sets the stage
for PLM
- Reducing the challenges and cost associated with regulatory compliance
- The nature of the pharmaceutical drug pipeline is changing
- Complexity of pharmaceutical products is increasing
- The end of the Blockbuster era signifies more candidates in the
pipeline
- Successful PLM for the pharmaceutical industry prevails over several
constraining factors
- Repurposing software from other industries makes the pharmaceutical
industry suspicious
- The traditional autonomous-business-unit mentality inhibits adoption
of PLM
- PLM does not mean an antidote to new product development
- ACTIONS
- Articulate strategic business benefits of your PLM investment decisions
- Take a holistic approach to PLM
- Understand how PLM changes the lifecycle processes of a pharmaceutical
product
- Optimizing PLM Technology for the Pharmaceutical Industry (technology
Focus)
- Summary
- PLM technology should align to the pharmaceutical industry' s business
challenges
- Digitizing research information earlier in the product lifecycle is an
essential first step towards PLM
- The electronic notebook offers an entry point to a connected and
global product management system
- PLM links disparate technologies offering a single point of truth for
each drug in development
- Alleviating risks of non-compliance is a key application for PLM in
the pharmaceutical industry
- Six technology features reflect how PLM technology is aligned to the
industry
- Scalability places SOA at the center of a PLM solution
- A quality-by-design feature facilitates compliance
- PLM must integrate with ERP solutions
- A web-enabled PLM solution matches the global nature of most
pharmaceutical organizations
- A easy-to-configure user interface drives adoption amongst both
scientists and engineers
- The industry is most comfortable with non-hosted solutions
- PLM technology adoption differs across geographies
- Japan and China will experience the fastest growth in PLM
- ACTIONS
- Offer technology features that speak to the customer' s business goals
- Make PLM a core part of the customer' s every day life
- Consider geography as a criterion for prioritizing your target market
- Managing Process Complexity with PLM (Strategy Focus)
- Summary
- Pharmaceutical product lifecycle management technology is gaining
momentum
- A variety of challenges is fueling PLM adoption in the pharmaceutical
industry
- Cultural and technological barriers have inhibited wider adoption of
PLM in the pharmaceutical market
- PLM in the pharmaceutical industry is poised for strong growth and
vendors have an important role to play
- PLM in the life sciences should map to business processes, managing
process complexity
- Pharmaceutical companies produce what they discover, not what they
invent
- The pharmaceutical sector looks for PLM that can manage process
complexity
- PLM is successful when handled as an enterprise, strategic initiative
- As part of a company' s product development business strategy, PLM is
discussed among executives
- Collaboration, through enterprise PLM, breaks down individual silos
- Reducing drug development costs is a major strategic goal for
implementing enterprise PLM
- The benefits of an enterprise-wide PLM solution do come with risks
- A phased implementation approach is most likely for pharmaceutical
organizations
- Partnering with a technology vendor may be a necessary PLM strategy
- A long-term commitment to the project indicates a willingness to share
risk
- Innovative and flexible vendors will attract most business
- Implementation efficiency is an important vendor characteristic
- Track record of success reflects on a vendor' s reliability and
trustworthiness
- ACTIONS
- PLM must support executive-level decisions
- Have a long-term vision but establish short-term milestones
- Look beyond point solutions for a strategic approach to PLM
- Pharmaceutical Product Lifecycle Management Forecast in North America
2006-2012 (Databook)
- iNTRODUCTION
- Definitions
- Total PLM spending in the pharmaceutical industry in North America
- Total pharmaceutical PLM spending in North America by technology segment
- US PLM spending in the pharmaceutical industry 2006-2012
- Canada PLM spending in the pharmaceutical industry 2006-2012
- Total North America PLM spending in the pharmaceutical industry by sector
- Global PLM spending by geographic region
- Pharmaceutical Product Lifecycle Management Forecast in Western Europe
2006-2012 (Databook)
- iNTRODUCTION
- Definitions
- Total PLM spending in the pharmaceutical industry in Western Europe
- Total pharmaceutical PLM spending in Western Europe by technology segment
- Total pharmaceutical PLM spending in Western Europe by sector
- France PLM spending in the pharmaceutical industry 2006-2012
- Germany PLM spending in the pharmaceutical industry 2006-2012
- UK PLM spending in the pharmaceutical industry 2006-2012
- Italy PLM spending in the pharmaceutical industry 2006-2012
- Spain PLM spending in the pharmaceutical industry 2006-2012
- Switzerland PLM spending in the pharmaceutical industry 2006-2012
- Global PLM spending by geographic region
- Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012
(Databook)
- iNTRODUCTION
- Definitions
- Global PLM spending by geographic region
- Total PLM spending in the pharmaceutical industry in APAC
- China PLM spending in the pharmaceutical industry 2006-2012
- Japan PLM spending in the pharmaceutical industry 2006-2012
- Total APAC PLM spending in the pharmaceutical industry by sector
- APPENDIX
- Definitions
- Abbreviations
- Methodology
- Further reading
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- List of Tables
- Table 1: Total PLM spending in the pharmaceutical industry in North
America
- Table 2: Total pharmaceutical PLM spending in North America by
technology segment
- Table 3: US PLM spending in the pharmaceutical industry 2006-2012
- Table 4: Canada PLM spending in the pharmaceutical industry 2006-2012
- Table 5: Total North America PLM spending in the pharmaceutical
industry by sector
- Table 6: Global PLM spending by geographic region
- Table 7: Total PLM spending in the pharmaceutical industry in Western
Europe
- Table 8: Total pharmaceutical PLM spending in Western Europe by
technology segment
- Table 9: Total pharmaceutical PLM spending in Western Europe by sector
2006-2012
- Table 10: France PLM spending in the pharmaceutical industry 2006-2012
- Table 11: Germany PLM spending in the pharmaceutical industry 2006-2012
- Table 12: UK PLM spending in the pharmaceutical industry 2006-2012
- Table 13: Italy PLM spending in the pharmaceutical industry 2006-2012
- Table 14: Spain PLM spending in the pharmaceutical industry 2006-2012
- Table 15: Switzerland PLM spending in the pharmaceutical industry
2006-2012
- Table 16: Global PLM spending by geographic region
- Table 17: Global PLM spending by geographic region
- Table 18: Total PLM spending in the pharmaceutical industry in APAC
- Table 19: China spending in the pharmaceutical industry 2006-2012
- Table 20: Japan PLM spending in the pharmaceutical industry 2006-2012
- Table 21: Total North America PLM spending in the pharmaceutical
industry by sector
- List of Figures
- Figure 1: The pharmaceutical product lifecycle is highly regulated,
more complex and longer than other industries
- Figure 2: Drug discovery licensing dependence of the top 10
pharmaceutical companies
- Figure 3: PLM spending in the pharmaceutical market is set for strong
growth over the next five years
- Figure 4: PLM in relation to ERP, CRM and BI
- Figure 5: PLM software must evolve to configurable packages to better
meet the pharmaceutical industry' s needs
- Figure 6: Global PLM spending by geographic region
- Figure 7: In the pharmaceutical industry, complexity in the process
defines the product
- Figure 8: Making a value proposition for PLM as a strategy in the
pharmaceutical product lifecycle
- Figure 9: As the Big Pharma begins to face its information management
needs, enterprise PLM investments will grow
- Figure 10: Examples of "must-have" and "nice-to-have" criteria
pharmaceutical companies use for selecting a PLM vendor as potential
partner
- Figure 11: Total PLM spending in the pharmaceutical industry in North
America
- Figure 12: Total pharmaceutical PLM spending in North America by
technology segment
- Figure 13: US PLM spending in the pharmaceutical industry 2006-2012
- Figure 14: Canada PLM spending in the pharmaceutical industry 2006-2012
- Figure 15: Total North America PLM spending in the pharmaceutical
industry by sector
- Figure 16: Global PLM spending by geographic region
- Figure 17: Total PLM spending in the pharmaceutical industry in
Western Europe
- Figure 18: Total pharmaceutical PLM spending in Western Europe by
technology segment
- Figure 19: Total pharmaceutical PLM spending in Western Europe by
sector 2006-2012
- Figure 20: France PLM spending in the pharmaceutical industry 2006-2012
- Figure 21: Germany PLM spending in the pharmaceutical industry
2006-2012
- Figure 22: UK PLM spending in the pharmaceutical industry 2006-2012
- Figure 23: Italy PLM spending in the pharmaceutical industry 2006-2012
- Figure 24: Spain PLM spending in the pharmaceutical industry 2006-2012
- Figure 25: Switzerland PLM spending in the pharmaceutical industry
2006-2012
- Figure 26: Global PLM spending by geographic region
- Figure 27: Global PLM spending by geographic region
- Figure 28: Total PLM spending in the pharmaceutical industry in APAC
- Figure 29: China spending in the pharmaceutical industry 2006-2012
- Figure 30: Japan PLM spending in the pharmaceutical industry 2006-2012
- Figure 31: Total APAC PLM spending in the pharmaceutical industry by
sector
|
Related Report
|
View Cart
